This proposal seeks to test the hypothesis that there are complex factors that affect SIV and HIV-1 replication and fitness in the host that have not yet been defined using standard cell culture or immunological assays. We have identified highly related SIVMne variants that are prototype viruses from early- and late-stage infection, respectively, which show dramatic difference in their replication and pathogenic properties. Such differences make these variants valuable tools for examining why and how certain viruses are selected for survival and persistence in the face of the host's immune response. The goal of the proposed studies is to determine the mechanism(s) that confer increased fitness to the latest age variants. Interestingly, our preliminary studies suggest that the late-stage variants continue to undergo considerable selection after they are transmitted to a new host, including predicted changes in glycosylation. Glycosylation changes typically indicate humoral immune selection, but we were unable to detect neutralizing antibodies using standard assay conditions in our initial studies. Our recent preliminary studies suggest that neutralizing antibody responses may develop at later times in these animals. We propose to explore the basis for the selection of these variants of the late-stage virus, and determine what factors contribute to the continued variation and positive selection of new viruses. This will include a more detailed analysis of antibody-mediated antiviral mechanisms, including analysis of the temporal development of both neutralizing and Fc-mediated antibody responses. These data will be compared with sequence studies to determine if viruses with glycosylation changes emerge after these antibodies are detected. Our studies will also address whether viral divergence is dependent on the fitness and replication properties of the infecting virus strain. In the course of the proposed studies, we hope to define a cell culture model system that predicts the increased replication fitness observed in the animals. Such a system would be broadly useful for predicting replication capacity and fitness and associated pathogenic properties of other viral strains of SIV and HIV. Collectively these studies will define the interplay between the properties of the infecting virus, the immune response and replication fitness in SIV/HIV pathogenesis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI034251-14
Application #
7395052
Study Section
AIDS Molecular and Cellular Biology Study Section (AMCB)
Program Officer
Sharma, Opendra K
Project Start
1993-05-01
Project End
2009-02-28
Budget Start
2008-03-01
Budget End
2009-02-28
Support Year
14
Fiscal Year
2008
Total Cost
$356,257
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Voronin, Yegor; Holte, Sarah; Overbaugh, Julie et al. (2009) Genetic drift of HIV populations in culture. PLoS Genet 5:e1000431
Graham, Susan M; Holte, Sarah; Kimata, Jason T et al. (2009) A decrease in albumin in early SIV infection is related to viral pathogenicity. AIDS Res Hum Retroviruses 25:433-40
Eastman, Dawnnica; Piantadosi, Anne; Wu, Xueling et al. (2008) Heavily glycosylated, highly fit SIVMne variants continue to diversify and undergo selection after transmission to a new host and they elicit early antibody dependent cellular responses but delayed neutralizing antibody responses. Virol J 5:90
Pineda, Mario Javier; Orton, Brannon R; Overbaugh, Julie (2007) A TRIM5alpha-independent post-entry restriction to HIV-1 infection of macaque cells that is dependent on the path of entry. Virology 363:310-8
Voronin, Yegor; Chohan, Bhavna; Emerman, Michael et al. (2007) Primary isolates of human immunodeficiency virus type 1 are usually dominated by the major variants found in blood. J Virol 81:10232-41
Voronin, Yegor; Overbaugh, Julie; Emerman, Michael (2005) Simian immunodeficiency virus variants that differ in pathogenicity differ in fitness under rapid cell turnover conditions. J Virol 79:15091-8
Zhang, Ming; Gaschen, Brian; Blay, Wendy et al. (2004) Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin. Glycobiology 14:1229-46
Dooher, Julia E; Pineda, Mario Javier; Overbaugh, Julie et al. (2004) Characterization of virus infectivity and cell-free capsid assembly of SIVMneCL8. J Med Primatol 33:262-71
Williams, Dawnnica; Overbaugh, Julie (2004) A real-time PCR-based method to independently sample single simian immunodeficiency virus genomes from macaques with a range of viral loads. J Med Primatol 33:227-35
Forte, Serene; Harmon, Mary-Elizabeth; Pineda, Mario J et al. (2003) Early- and intermediate-stage variants of simian immunodeficiency virus replicate efficiently in cells lacking CCR5. J Virol 77:9723-7

Showing the most recent 10 out of 23 publications